These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16864147

  • 1. Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women.
    Morgante G, Delia A, Musacchio MC, Severi FM, Petraglia F, De Leo V.
    Gynecol Endocrinol; 2006 Jul; 22(7):376-80. PubMed ID: 16864147
    [Abstract] [Full Text] [Related]

  • 2. Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women.
    Sumino H, Ichikawa S, Kasama S, Takahashi T, Kumakura H, Takayama Y, Kanda T, Murakami M, Kurabayashi M.
    Geriatr Gerontol Int; 2010 Jan; 10(1):70-7. PubMed ID: 20102385
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.
    Lasco A, Gaudio A, Morini E, Morabito N, Nicita-Mauro C, Catalano A, Denuzzo G, Sansotta C, Xourafa A, Macrì I, Frisina N.
    Menopause; 2006 Jan; 13(5):787-92. PubMed ID: 16912660
    [Abstract] [Full Text] [Related]

  • 4. Effect of raloxifene on the vaginal epithelium of postmenopausal women.
    Delmanto A, Nahas-Neto J, Nahas EA, de Oliveira ML, Fernandes CE, Traiman P.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):187-92. PubMed ID: 18400357
    [Abstract] [Full Text] [Related]

  • 5. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K.
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cognitive function in postmenopausal women treated with raloxifene.
    Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, Nickelsen T, Multiple Outcomes of Raloxifene Evaluation Investigators.
    N Engl J Med; 2001 Apr 19; 344(16):1207-13. PubMed ID: 11309635
    [Abstract] [Full Text] [Related]

  • 9. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C.
    Menopause; 2006 Apr 19; 13(4):660-8. PubMed ID: 16837888
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B, Kirmaz C, Aydin K, Kafesciler SO, Guclu F, Hekimsoy Z.
    Eur Cytokine Netw; 2007 Sep 19; 18(3):148-53. PubMed ID: 17823083
    [Abstract] [Full Text] [Related]

  • 12. The effect of raloxifene on cardiac autonomic regulation in osteoporotic women.
    Gol M, Baris N, Guneri S, Posaci C.
    Am J Obstet Gynecol; 2006 May 19; 194(5):1249-54. PubMed ID: 16647907
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J, Sumino H, Ichikawa S, Ozaki M.
    Am J Hypertens; 2006 Jul 19; 19(7):744-9. PubMed ID: 16814131
    [Abstract] [Full Text] [Related]

  • 17. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL, Song J, Dowsett SA, Mershon JL, Delmas PD, Secrest RJ, Cauley JA.
    Curr Med Res Opin; 2008 Mar 19; 24(3):807-13. PubMed ID: 18254988
    [Abstract] [Full Text] [Related]

  • 18. Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.
    Katz DL, Evans MA, Njike VY, Hoxley ML, Nawaz H, Comerford BP, Sarrel PM.
    Climacteric; 2007 Dec 19; 10(6):500-7. PubMed ID: 18049943
    [Abstract] [Full Text] [Related]

  • 19. The hemorheological effects of raloxifene in postmenopausal women with osteoporosis. Results of a 3-year placebo-controlled clinical trial.
    Shand B, Gilchrist N, Blackwell T, March R.
    Clin Hemorheol Microcirc; 2002 Dec 19; 26(4):249-55. PubMed ID: 12122230
    [Abstract] [Full Text] [Related]

  • 20. Raloxifene: bone and cardiovascular effects.
    Francucci CM, Romagni P, Boscaro M.
    J Endocrinol Invest; 2005 Dec 19; 28(10 Suppl):85-9. PubMed ID: 16550730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.